Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem … – Wall Street Journal
|
Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem …
Wall Street Journal Invitrx Therapeutics is a biotechnology company specializing in the culture and engineering of adult stem cells, innovative products and therapies that are used in aesthetics, wound closure, and healing, as well as, plastic and reconstructive surgery … |



